These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26465368)

  • 1. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.
    Vidal JE; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.
    Boulware DR; Rolfes MA; Rajasingham R; von Hohenberg M; Qin Z; Taseera K; Schutz C; Kwizera R; Butler EK; Meintjes G; Muzoora C; Bischof JC; Meya DB
    Emerg Infect Dis; 2014 Jan; 20(1):45-53. PubMed ID: 24378231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
    Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
    Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
    PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing.
    Rajasingham R; Wake RM; Beyene T; Katende A; Letang E; Boulware DR
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30257903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
    Williams DA; Kiiza T; Kwizera R; Kiggundu R; Velamakanni S; Meya DB; Rhein J; Boulware DR
    Clin Infect Dis; 2015 Aug; 61(3):464-7. PubMed ID: 25838287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil.
    Vianna CMM; Mosegui GBG
    Rev Inst Med Trop Sao Paulo; 2021; 63():e57. PubMed ID: 34231822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
    Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
    BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.
    Longley N; Jarvis JN; Meintjes G; Boulle A; Cross A; Kelly N; Govender NP; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2016 Mar; 62(5):581-587. PubMed ID: 26565007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Cryptococcus capsular polysaccharide detection FungiXpert LFA (lateral flow assay) for the rapid diagnosis of Cryptococcosis.
    Liu Y; Kang M; Wu SY; Wu LJ; He L; Xiao YL; Zhang WL; Liao QF; Deng J; Chen ZX; Ma Y
    Med Mycol; 2022 Apr; 60(4):. PubMed ID: 35362524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immunomycologics Lateral Flow Assay.
    Wake RM; Jarvis JN; Harrison TS; Govender NP
    J Acquir Immune Defic Syndr; 2018 Aug; 78(5):574-578. PubMed ID: 29771787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
    Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
    Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa.
    Drain PK; Hong T; Krows M; Govere S; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Bassett IV; Celum C
    Sci Rep; 2019 Feb; 9(1):2687. PubMed ID: 30804356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
    Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
    J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
    Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
    BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
    Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
    BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of point of care serum cryptococcal antigen by lateral flow immunoassay for diagnosis of cryptococcosis and cryptococcal meningitis in HIV-positive patients.
    Kamble U; Dheeresh KH; Bhosale K; Indu MB; Sharma B; Chowdhary A
    Indian J Sex Transm Dis AIDS; 2021; 42(1):14-18. PubMed ID: 34765932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
    Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
    Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.